Eaton Vance Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-2,174
Closed -$231K 932
2014
Q2
$231K Buy
+2,174
New +$213K ﹤0.01% 864

Eaton Vance Management's FURX Position: Q3 2014 in Review

Eaton Vance Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 2,174 shares — an estimated $231K sold.

Eaton Vance Management first reported a position in FURX in Q2 2014 and held it in 1 quarter. The position peaked at $231K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Eaton Vance Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Eaton Vance Management sold 2,174 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $231K.
  • Eaton Vance Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Eaton Vance Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $231K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Eaton Vance Management's 13F filing for Q3 2014, filed 10 Nov 2014.